The global genotyping market is estimated to grow at a CAGR of 22.3% from 2015 to 2020 to reach $17.0 Billion in 2020. Advances in technology, decreasing prices of DNA sequencing, increasing incidence and awareness on genetic diseases & personalized medicine, increasing demand for pharmacogenomics in drug discovery & development, and the increased use of genetic analysis in animal & plant livestock are the major factors driving market growth.

Get Free Brochure:https://www.marketsandmarkets.com/pdfdownload.asp?id=249958595

Other drivers include the increasing application areas of genotyping, increasing demand for affordable genotyping services, increasing access to healthcare, and growing investments by leading players in emerging markets. However, the lack of well-trained technical personnel and proper reimbursement are some major factors that could hinder the growth of this market to a certain extent.

The market studied in this report is mainly segmented by products, technologies, applications, and end users. Based on product, the market is segmented into instruments (sequencers, & analyzers), reagents & kits, and bioinformatics software and services. Reagents & kits market is forecasted to grow at a highest CAGR of 24.9% during the forecast period owing to its increasing demand with increasing applications of genotyping tests. On the basis of application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The high growth in this segment is attributed to increasing use of genotyping in drug development process & to analyze the effects of drug.

The global genotyping market is dominated by North America, followed by Europe. The Asia-Pacific market is expected to witness the highest growth due to the growing healthcare infrastructure, improving healthcare services, increasing investments by major players and governments, and increasing clinical research activities. North America and Europe are expected to grow at a sluggish rate since these are relatively saturated markets.

Get Detailed Information: https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html

Prominent players in this market are Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.).

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]